Taiwan has become the latest APAC region to approve the use of 2’-fucosyllactose (2’-FL) – a human milk oligosaccharide (HMO) – in nutrition products for infant and young children, with firms hopeful of further sector growth as more authorities permit the use of the ingredient.

Read more here